Fecal microbiota transplantation restores gut microbiota diversity in children with active Crohn's disease: a prospective trial/Experiment 3
From BugSigDB
Reviewed Marked as Reviewed by KateRasheed on 2025-5-12
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Response to transplant Response to transplant,response to transplant
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Healthy donors
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Crohn’s disease (FMT0W) (Fecal microbiota transplantation before treatment)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Crohn's disease before (fecal microbiota transplantation) FMT treatment
- Group 0 sample size Number of subjects in the control (unexposed) group
- 16
- Group 1 sample size Number of subjects in the case (exposed) group
- 17
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- Kruskall-Wallis
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- decreased
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- increased
- Richness Number of species
- decreased
Signature 1
Reviewed Marked as Reviewed by KateRasheed on 2025-5-12
Source: Supplementary figure 4
Description: Relative abundance of bacteria between healthy donor group and pre-FMT (pre-fecal microbiota transplantation)
Abundance in Group 1: decreased abundance in Crohn’s disease (FMT0W) (Fecal microbiota transplantation before treatment)
| NCBI | Quality Control | Links |
|---|---|---|
| Agathobacter | ||
| Akkermansia | ||
| Anaerostipes | ||
| Blautia | ||
| Faecalibacterium | ||
| Roseburia | ||
| Streptococcus | ||
| Subdoligranulum |
Signature 2
Reviewed Marked as Reviewed by KateRasheed on 2025-5-12
Source: Supplementary Figure 4
Description: Relative proportion of bacteria between healthy donor group and pre-FMT (pre-fecal microbiota transplantation)
Abundance in Group 1: increased abundance in Crohn’s disease (FMT0W) (Fecal microbiota transplantation before treatment)
| NCBI | Quality Control | Links |
|---|---|---|
| Clostridioides |
